Exploring RNA Technology and Investment in Europe

This chapter examines the landscape of RNA technology in Europe, discussing its potential applications in healthcare and agriculture, as well as the challenges it faces in attracting investment. The speakers share insights from their groundbreaking report, highlighting the current state of RNA companies, patenting issues, and the need for a strategic framework to support growth in this sector. Emphasizing the disparity in funding and regulatory hurdles, the chapter underscores the importance of enhancing trust and investment in European biotech to unlock its full potential.